We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
-0.77%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$7.55B
AUM Growth
-$472M
(-5.9%)
Cap. Flow
-$301M
Cap. Flow
% of AUM
-3.99%
Top 10 Holdings %
Top 10 Hldgs %
20.77%
Holding
863
New
59
Increased
344
Reduced
256
Closed
128
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$25.4M |
| 2 |
AbbVie
ABBV
|
+$21.9M |
| 3 |
KYNB
Kyntra Bio
KYNB
|
+$19.2M |
| 4 |
Waste Management
WM
|
+$19M |
| 5 |
Gilead Sciences
GILD
|
+$17.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$70.2M |
| 2 |
ARRY
Array Biopharma Inc
ARRY
|
+$45.8M |
| 3 |
Biogen
BIIB
|
+$43.3M |
| 4 |
Meta Platforms (Facebook)
META
|
+$24.8M |
| 5 |
Amgen
AMGN
|
+$21.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 31.81% |
| 2 | Technology | 18.27% |
| 3 | Financials | 10.05% |
| 4 | Consumer Discretionary | 9.39% |
| 5 | Communication Services | 7.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
SK Telecom
SKM
$13.7B
| $395K | 0.01% |
10,789
+1,126
| +12% | +$42.2K |
|
677
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.9B
| $388K | 0.01% |
+13,298
| New | +$371K |
|
678
Codexis
CDXS
$135M
| $376K | 0.01% |
27,444
| – | – |
|
679
Restaurant Brands International
QSR
$25.1B
| $363K | ﹤0.01% |
5,099
+703
| +16% | +$51.8K |
|
680
Hubbell
HUBB
$25.7B
| $352K | ﹤0.01% |
2,676
-4,051
| -60% | -$522K |
|
681
Altria Group
MO
$122B
| $335K | ﹤0.01% |
8,180
| – | – |
|
682
Autohome
ATHM
$2.43B
| $333K | ﹤0.01% |
+4,000
| New | +$343K |
|
683
Avery Dennison
AVY
$12.3B
| $331K | ﹤0.01% |
2,918
+593
| +26% | +$67.7K |
|
684
Cenovus Energy
CVE
$54.6B
| $324K | ﹤0.01% |
34,464
+330
| +1% | +$3K |
|
685
Gildan
GIL
$9.25B
| $323K | ﹤0.01% |
+9,095
| New | +$342K |
|
686
Franco-Nevada
FNV
$41.4B
| $312K | ﹤0.01% |
3,419
-10,022
| -75% | -$919K |
|
|
YELL
687
DELISTED
Yellow Corporation Common Stock
YELL
| $305K | ﹤0.01% |
+101,000
| New | +$318K |
|
688
Spectrum Brands
SPB
$2.04B
| $293K | ﹤0.01% |
+5,558
| New | +$290K |
|
689
Vale
VALE
$62.9B
| $288K | ﹤0.01% |
25,056
-69
| -0.3% | -$836 |
|
|
KL
690
DELISTED
Kirkland Lake Gold Ltd Ordinary
KL
| $277K | ﹤0.01% |
+6,189
| New | +$283K |
|
691
Affiliated Managers Group
AMG
$9.46B
| $261K | ﹤0.01% |
3,132
+72
| +2% | +$6.02K |
|
|
KDNY
692
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $253K | ﹤0.01% |
47,800
| – | – |
|
|
LITS
693
Lite Strategy Inc
LITS
$33.6M
| $252K | ﹤0.01% |
7,500
-18,000
| -71% | -$656K |
|
694
Ralph Lauren
RL
$22.2B
| $252K | ﹤0.01% |
2,644
-3,919
| -60% | -$388K |
|
695
Sea Limited
SE
$61.2B
| $248K | ﹤0.01% |
+8,000
| New | +$269K |
|
696
Agnico Eagle Mines
AEM
$72.6B
| $242K | ﹤0.01% |
4,505
+45
| +1% | +$2.55K |
|
|
SEE
697
DELISTED
Sealed Air
SEE
| $242K | ﹤0.01% |
+5,828
| New | +$247K |
|
698
State Street SPDR S&P Biotech ETF
XBI
$10.2B
| $239K | ﹤0.01% |
3,130
-1,065
| -25% | -$88.5K |
|
699
Cooper Companies
COO
$13.7B
| $235K | ﹤0.01% |
3,168
-9,660
| -75% | -$779K |
|
700
Uber
UBER
$134B
| $225K | ﹤0.01% |
+7,400
| New | +$278K |
|
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q3 2019 Portfolio in Review
As of Q3 2019, Candriam SCA held 863 positions worth $7.55B, down 5.9% from $8.02B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Candriam SCA withdrew a net $301M in Q3 2019, closing 128 positions and reducing 256 holdings. Its most notable exit was Celgene Corp, an estimated $70.2M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 33% a quarter earlier, followed by Technology and Financials.
Against the trend, Candriam SCA opened a new position in Nike worth $27.8M.
- Candriam SCA's largest Q3 2019 buy was Nike: 295,763 shares worth $27.8M.
- Candriam SCA added most to AbbVie in Q3 2019, an estimated $21.9M increase.
- Candriam SCA's biggest Q3 2019 reduction was Biogen, cutting an estimated $43.3M.
- Candriam SCA fully exited Celgene Corp in Q3 2019, selling an estimated $70.2M.
- Candriam SCA's ten largest holdings make up 21% of its $7.55B portfolio in Q3 2019.
- Candriam SCA opened 59 new positions and closed 128 in Q3 2019.
- Candriam SCA's portfolio value fell 5.9% quarter-over-quarter to $7.55B.
Based on Candriam SCA's 13F filing for Q3 2019, filed 21 Oct 2019.